My understanding is Bisantrene would enable heavier and more frequent doses of pre-existing products. If Bisantrene belongs to a competitor, you have the same issue re: patients getting better treatment - so why not just be the one go buy it?
My understanding is Bisantrene would enable heavier and more...
-
- There are more pages in this discussion • 211 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
-0.115(7.03%) |
Mkt cap ! $259.1M | |||
| Open | High | Low | Value | Volume |
| $1.62 | $1.63 | $1.52 | $167.4K | 104.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2239 | $1.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 391 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |